A review of earlier clinical studies on neuroprotective agents and current approaches

International Review of Neurobiology

Volumn , Issue 40, 1996, Pages 337-363

  Wahlgren, Nils Gunnar ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPROTECTIVE AGENT;

ACUTE DISEASE; ANIMAL; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ACUTE DISEASE; ANIMALS; CEREBROVASCULAR DISORDERS; CLINICAL TRIALS; HUMANS; NEUROPROTECTIVE AGENTS; RANDOMIZED CONTROLLED TRIALS;

EID: 0030640779     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0074-7742(08)60727-8     Document Type: Article

References (192)

1. Abel, M.S. & McCandless, D.W. (1992) Elevated y-aminobuturic acid levels attenuate the metabolic response to bilateral ischaemia. J. Jfeurochem. 58, 740-744.
2. Adamni, A.K. (1978) New approach to treatment of recent stroke. Br. Med.J. 2, 1678-1679.
3. Albcrs, G.W., Saenz, R.E., Moses,J.A. & Choi, D.W. (1991) Safety and tolerance of oral dextromethorphan in patients at risk for brain ischaemia. Stroke 22, 1075-1077.
4. Albers, G.W, Atkinson, R.P., Kellcy, R.E. & Rosenbaum, D.M. (1995) Safety, tolerability, and pharmacokinetics of the .A-metyl-D-aspartate antagonist dextrorphan in patients with acute stroke. Stroke 76, 254-258.
5. Alien, G.S., Ahn, H.S., Prcziosi, TJ., Battye, R., Boone, S.C., Chou, S.N., Kelly, D.L., Weir, B.K., Crabbe, R.A., Lavik, PJ., Rosenbloom, S.B., Dorsey, F.C., Ingram, C.R., Mellits, D.E., Bertsch, L.A., Boisvert, PJ., Hundley, M.B., Johnson, R.K., Strom, J.A. & Transou, C.R. (1983) Cerebral artery spasm - a controlled trial of nimodipine in patients with subarachnoid haemorrhage. JNfrti EngLJ. Med. 308, 619-624.
6. Alter, M., for the SASS investigators (1994) Ganglioside GM1 in acute ischaemic stroke; the SASS trial. Stroke 25, 1141-1148.
7. Ames, A., Wright, L., Lowade, M., Thurston, J.M. & Majors, G. (1968) Cerebral ischaemia: the no-reflow phenomenon. Am. J. Pathol. 52, 437-453.
8. Angcleri, E, Scarpino, O., Martinazzo, C., Mauro, A., Magi, M., Pelliccioni, G., Rapex, G. & Bruno, R. (1992) GM1 ganglioside therapy in acute ischaemic stroke. Cerebrovasc. Dis. 2, 163-168.
9. Argentino, G., Sacchetti, M.L., Toni, D., Savoini, G., D'Arcangelo, E., Erminio, E, Federico, F., Milone, F., Gallai, V, Gambi, D., Mamoli, A., Ottonello, G.A., Ponari, O., Rebucci, G., Senin, U. & Fieschi, C. (1989) GM1 gangloside therapy in acute ischaemic stroke. Stroke 20, 1143-1149.
10. Azcona, A. & Lataste, X. (1990) Isradipine in patients with acute ischaemic cerebral infarction: An overview of the ASCLEPIOS programme. Drugs 40 (Suppl. 2), 52-57.
11. Baldwin, H.A., Jones, J.A., Cross, AJ. & Green, A.R. (1993) Histological, biochemical and behavioural evidence for the neuroprotective action of clormethiazole following prolonged carotid artery occlusion. jVeurodegeneralion 2, 139-146.
12. Barer, D.H., CruickshankJ.M., Ebrahim, S.B. & MitchellJ.R.A. (1988) Low dose beta-block ade in acute stroke ('BEST' trial): an evaluation. Br. MedJ. 296, 737-741.
13. Barnard, E.A., Darlison, M.G. & Seebury, P. (1987) Molecular biology of the GABAA receptor: the receptor/channel superfamily. Trends Neurosn. 10,502-509.
14. Barone, EG., Schmidt, D.B., Hillegass, L.M., Price, WJ., White, R.F., Feuerstein, G.Z., Clark, R.K. & Lee, E.V. (1992) Reperfusion increases neutrophils and leucotriene B4 receptor binding in rat focal ischaemia. Stroke 23, 1337-1348.
15. Bassi, S., Albizzati, M.G., Sbacchi, M., Frattola, L. & Massarotti, M. (1984) Double-blind evaluation of monoganglioside (GM1) therapy in stroke. J. Neurosti. Res. 12, 493-498.
16. Battistin, L., Cesari, A., Galligioni, F., Marin, G., Massarotti, M., Paccagnella, D., Pellegrini, A., Testa, G. & Tonin, P. (1985) Effects GM1 ganglioside in cerebrovascular diseases: A double-blind trial in 40 cases. EUT. Xeurol. 24, 343-351.
17. Berger, L., Marchai, G. & Hakim, A.M. (1987) A preliminary PET evaluation of nimodipine in stroke. J. Cereb. Blood Flow Metab. 7 (Suppl. 1), S160.
18. Beyderer,J. (1983) Use of pentoxyfylline in the treatment of acute cerebrovascular insufficiency. Ear. Xeurol. 22 (Suppl. 1), 116-123.
19. Bjorklund, A. & Stencvi, U. (1979) Regeneration of monoaminergic and cholinergic neurones in the mammalian central nervous system. Phjsiol. Rev. 59, 62-100.
20. Boast, C.A., Gerhard, S.C. and Pastor, G. et al. (1988) The jV-methyl-D-aspartate antago-nists. CGS19755 and CPP reduce ischaemic brain damage in gerbils. Brain Res. 442, 395-398.
21. Bogousslavsky, J., Regli, E, Zumstein, V. & Kobberling, W. (1990) Double-blind study of nimodipine in non-severe stroke. EUT. Neural. 30, 23-26.
22. Bowes, M.P., Zivin,J.A. & Rothlein, R. (1993) Monoclonal antibody to the ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model. Exp. Neurol. 119,215-219.
23. Bridgers, S.L., Koch, G., Munera, C., Karwon, M. & Kurtz, N. (I991) Intravenous nimodipine in acute stroke: interim analysis of randomized trials. Stroke 22, 153.
24. Buchan, A.M. (1990) Do NMDA antagonists protect against cerebral ischaemia: Are clinical trials warranted? Cerebrorasc. Brain Melabol. Rev. 2, 1-26.
25. Buchan, A.M., Xue, D., Slivka, A., Zhang, C., Hamilton, J. & Gelb, A. (1989) MK-801 increases cerebral blood flow in a rat model of temporary focal cortical ischaemia. Soc. Neuroid. Abstr. 15, 804.
26. Buchkremer-Ratzmann, I. & Witte, O.W. (1995) Peri-infarct and trans-hemispheric diaschisis caused by photothrombotic infarction in rat neocortex is reduced by lubeluzole but not MK801. J. Cereb. Blood Flow Metab. 15 (Suppl. 1), S38.
27. Cao, X. & Phillis, J.W. (1994) a-Phenyl-butyl-nitrone reduces cortical infarct and oedema in rats subjected to focal ischaemia. Brain Res. 644, 267-272.
28. Carolei, A., Fieschi, C., Bruno, R. & Toffano, G. (1991) Monosialoganglioside GM1 in cere bral ischaemia. Cerebroi'asc. Brain MeTable Rev. 3, 134-157.
29. Chan, P. (1994) Oxygen radicals in focal cerebral ischaemia. Brain Pathol. 4, 59-65.
30. Choi, D.W. (1990) Methods for antagonizing glutamate toxicity. Cerebroiasc. Brain Metab Rev. 2, 105-1437.
31. Collingridge, G.L. & Bliss, T.V (1987) NMDA-receptors - their role in long-term potentiation. Trends Murosci. 10, 288-293.
32. Coté, R., Hachinski, VC., Shurvell, B.L., Norris, Y.W. & Wolfson, C. (1986) The Canadian Neurological Scale: A preliminary study in acute stroke. Stroke 17, 731-737.
33. Coull, B.M. (1994) Randomized trial of CGS 19755, a glutamate antagonist, in acute ischaemic stroke treatment. Abstract to the American Academy of Neurology annual meeting.
34. Cross, AJ., StirlingJ.M., Robinson, T.N., Bowen, D.M., Francis, P.T. & Green, A. (1989) The modulation by chlomethiazole of the GABA:\ receptor complex in rat brain. Br.J. Pharmacol. 98, 284-290.
35. Cross, A.J., Jones, J.A., Baldwin, H.A. & Green, A.R. (1991) Neuroprotective activity of chlomethiazole following transient forebrain ischaemia in the gerbil. Br.J. Pharmacol. 104, 406-411.
36. Curtis, D.R., Hosli, L., Johnston, G.A.R. &Johnston, I.H. (1968) Pharmacological study of the depression of spinal neurones by glycine related amino acids. Exp. Brain Res. 6, 1-18.
37. Czlonkowska, A. & Cyrta, B. (1988) Effect of naloxone on acute stroke. Pharmacopychialiy 21, 98-100.
38. Czlonkowska, A., Mendel, T. & Baranska-Gieruszczak, B. (1992) A double-blind controlled trial of naloxone in early treatment of acute ischaemic stroke. Cerebroi'asc. Dis. 2, 40-43.
39. Dal Toso, R., Skaper, S.D., Ferrari, G., Toffano, G. & Léon, A. (1988) Ganglioside involvement in membrane-mediated transfer of trophic information: relationship to GM1 effects following CNS injury. In Pharmacological Approaches to the Treatment of Brain and Spinal Cord Injury (eds Stein, D.G. & Säbel, B.A.), pp. 143-165. Plenum, New York.
40. De Deyn, P.P. (1995) The Piracetam in acute stroke study (PASS). Eur.J. MeuroL 2,1.
41. Dekoninck, WJ.,Jocquet, Ph.,Jacquy,J. & Henriet, M. (1978) Comparative study of the clinical effects of vincamine+glycerol versus glycerol+placebo in the acute phase of stroke. Arzneimittelforsch. 28, 1654-1657.
42. De Ryck, M., Keersmackers, R., Clincke, G.Janssen, M. & Van Reel, S. (1994) Lubeluzole, a novel benzothiazole, protects neurologic function after cerebral thrombotic stroke in rats: an apparent stereospecific effect. Soc. Neurosd. Abslr. 20, 185.
43. Desbourdes, J.M., Ades, P.E. & Guggiari, M. (1989) Nimodipine intraveineuse dans le traite-ment curatif du vasospasme cérébral secondaire aux hémorrhagies méningées par rupture anevrysmale: Étude comparative multicentrique. Agressologie 30, 438-140.
44. Diener, H.C., Hacke, \V., Hennerici, M., Râdberg, J., Hantson, L. & De Keyser.J., for thé Lubeluzole International Study Group (1996) Lubeluzole in acute ischaemic stroke. A double-blind placebo-controlled phase II trial. Stroke 27, 76-81.
45. Di Mascio, R., Marchioli, R. & Tognoni, G. (1994) From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders. Clinical Trials & Meta-analysis 29, 57-79.
46. Dustin, M.L., Rothlein, R., Bhan, A.K., Dinarello, C.A. & Springer, T.A. (1986) Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). J. Immunol. 137, 245-254.
47. Faden, A.I.,Jacobs, T.R & Holaday,J.W. (1981) Opiate antagonists improves neurologic recov-ery after spinal injury. Science 211, 493-494.
48. Fagg, G.E. & Foster, A.C. (1983) Amino acid neurotransmitters and their pathways in the mammalian central nervous system. Neuroscience 26, 701-719.
49. Fagg, G.E., Foster, A.C. & Ganong, A.H. (1986) Excitatory amino acid synaptic mechanisms and neurological function. Trends Pharmacol. Set. 7, 357-363.
50. Fallis, RJ., Fisher, M. & Lobo, R.A. (1984) A double blind trial of naloxone in the treatment of acute stroke. Stroke 15, 627-629.
51. Fisher, M. (1994) Cerestat (CNS 1102), a non-competitive NMDA antagonist in ischaemic stroke patients: Dose escalating safety study. Cerebrovasc. Dis. 4, 245.
52. Fisher, M. (1995) Potentially effective therapies for acute ischaemic stroke. Eur. Neural. 35, 3-7.
53. Fleischer, J., Tateishi, A., Drummond, J.C. et al. (1988) Effects of MK-801 upon neurological outcome following cardiac arrest in cats. Anesthesiol. Rev. 15, 102-103.
54. Frithz, G. & Werner, I. (1975) The effect of glycerol infusion in acute cerebral infarction. Acla. Med. Scand. 198, 287-289.
55. Gelmers, HJ. (1984) The effects of nimodipine on the clinical course of patients with acute ischaemic stroke. Acla. Neural. Scand. 69, 232-239.
56. Gelmers, HJ., Gorter, K., De Weerdt, CJ. & \Viezer, HJ.A. (1988) A controlled trial of nimodipine in acute ischaemic stroke. New Engl.J. Med. 318, 203-207.
57. Gelmers, HJ. & Hennerici, M. (1990) Effect of nimodipine on acute ischaemic stroke. Pooled results from five randomized trials. Stroke 21, IV-81-IV-84.
58. George, C.P., Goldberg, M.P., Choi, D.W. & Steinberg, G.K. (1988) Dextromethorphan reduces neocortical ischaemic neuronal damage in tiro. Brain Res. 440, 375-379.
59. Gill, R., Foster, A.C. & Woodruff, G.N. (1988) MK-801 is neuroprotective in gerbils when administered during the post-ischaemic period. Neuroscience 25, 847-855.
60. Gill, R., Foster, A.C. & Woodruff, G.N. (1989) Neuroprotective actions of MK-801 in rat global ischaemia model. J. Cereb. Blood Flow MeTable 9 (suppl. 1), S 629.
61. Giraldi, G., Masi, M.C., Manetti, M., Carabelli, E. & Martini, A. (1990) A pilot study with monoganglioside GM1 on acute cerebral ischaemia. Acta Neural. Nap. 12, 214-221.
62. Gotoh, O., Mohamed, A., McCulloch, J., Graham, D., Harper, A. & Teasdale, G. (1986) Nimodipine and the haemodynamic and histopathologic consequences of middle cerebral artery occlusion in the rat.J. Cereb. Blood Flow Metab. 6, 321-331.
63. Gotti, B., Benavides, J., McKenzie, E.T. & Scatton, B. (1990) The pharmacotherapy of focal cortical ischaemia in the mouse brain. Brain Res. 522, 290-307.
64. Graham, S.H., ChenJ., Lan,J., Leach, MJ. & Simon, R.P. (1994) Neuroprotective effect of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion. J. Pharmacol. Exp. TJier. 269, 854-859.
65. Gray, C.S., French.J.M., Venables, G.S., Cartlidge, N.E.F., James, O.F.W. & Bates, D. (1990) A randomized double-blind controlled trial of naftidrofuryl in acute stroke. Age Ageing 19, 356-363.
66. Green, A.R., Cross, A.J., Snape, M.F. & De Souza, RJ. (1992) The immediate consequences of middle cerebral artery occlusion on GABA synthesis in mouse cortex and cerebellum. Mumsci.Lett. 138, 141-144.
67. Greenberg, J.H., Uematsu, D., Araki, N., Hickey, W.F. & Reivich, M. (1990) Cytosolic free calcium during focal cerebral ischaemia and the effects of nimodipine on calcium and histological damage. Stroke 21 (Suppl. 4), 72-77.
68. Grotta,J. (1994) Safety and tolerability of the glutamate antagonists CGS 19755 in acute stroke patients. 19th International Joint Conference on Stroke and Cerebral Circulation. Stroke 25, 255.
69. Haley, E.C.Jr, Kassell, N.F., Alves, W.M., Weir, B.K. & Hansen, C.A. (1995) Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J.j\reurosurg. 82 (5), 786-90.
70. Hallebeck, J.M., Dutka, Aj., Tanishima, T., Kochanek, P.M., Kumaroo, K.K., Thompson, C., Obrenovitch, T.P. & Contreras, TJ. (1986) Polymorphonuclear leucocyte accumulation in brain regions with low blood flow during the early postischaemic period. Stroke 17, 246-253.
71. Harrison, N.L. & Simmonds, M.A. (1985) Quantitative studies on some antagonists of N-methyl-D-aspartate in slices of rat cerebral cortex. Br.J. Pharmacol. 84, 381-391.
72. Hasegawa, Y, Fisher, M., Baron, B.M. & Metcalf, G. (1994) The competitive NMDA antago-nist, MDL 100,453 reduces infarct size after experimental stroke. Stroke 25, 1241-1246.
73. Heiss, W.D., Holthoff, V, Pawlik, G. & Neveling, M. (1990) Effect of nimodipine on regional cerebral glucose metabolism in patients with acute ischaemic stroke as measured by positron emission tomography. J. Cereb. Blood Flow Afetab. 10, 127-132.
74. Heiss, W.D., Ilsen, H.W., Wagner, R., Pawlik, G. & Wienhard, K. (1983) Remote functional depression of glucose metabolism in stroke and its alteration by activating drugs. In Positron Emission Tomography of the Brain (eds Heiss, W.D. & Phelps, M.E.), pp. 162-168. Springer, Berlin-Heidelberg-New York.
75. Hennerici, M., Krämer G., North, P.M., Schmilz, H. & Tettenborn, D. (1994) Nimodipine in the treatment of acute MCA ischaemic stroke. Cmbroi-asc. Dis. 4, 189-193.
76. Hernandez, L.A., Grisham, M.B., Twohic, B., Arfors, K.E., Harlan, J.M. & Granger, D.N. (1987) Role of neutrophils in ischaemia-perfusion-induced mictrovascular injury. Am. J. Ptysiol. 253, H699-H703.
77. Herrschaft, H. (1988) Die Wirksamkeit von Piracetambei der akuten zerebralen Ischämie des Menschen. Klinisch kontrollierte Doppelblindstudie Piracetam/10% Dextran 40 versus 10% Dextran 40/Placebo. Med. Klin. 83, 667-677.
78. Hoflbrand, D.I., Bingley, PJ., Oppenheimer, S.M. & Sheldon, C.D. (1988) Trial of ganglioside GM l in acute stroke. J. jYturol. jYeurosurg. Psychiat. 51,1213-1214.
79. Holmes, B., Brogden, R.N., Heel, R.C., Speight, TM. & Avery, G.S. (1984) Flunarizine; A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drugs 27, 6-14.
80. Hosobuchi, Y, Baskin, W.S. & Woo, S.K. (1982) Reversal of induced ischaemic neurological deficit in gerbils by the opiate antagonist naloxone. Science 215, 69-71.
81. Hsu, C.Y., Faught, R.E., Furlan, AJ., Coull, B.M., Huang, D.C., Hogan, E.L., Linet, O.I. & Hatsu, EM. (1987) Intravenous prostacyclin in acute non-hemorrhagic stroke: A placebocontrolled double-blind trial. Stroke 18, 352-358.
82. Hsu, C.Y, Norris, J.W., Hogan, E.L., Bladin, P., Dinsdale, H.B., Yatsu, F.M., Earnest, M.P., Schcinberg, P., Caplan, L.R., Karp, H.R., Swanson, P.D., Feldman, R.G., Cohen, M.M., Mayman, G.I., Cobert, B. & Savitsky,J.P. (1988) Pentoxiphylline in acute non-hemorrhagic stroke. A randomized, placebo-controlled double-blind trial. Stroke 19, 716-722.
83. Huber, M., Kittner, B., Hojer, C., Fink, C.R., Neveling, M. & Heiss, W.D. (1993) Effect of propentophylline on regional cerebal glucose metabolism in acute ischaemic stroke, jf. Cereb. Blood Haw Metab. 13, 526-530.
84. Huczynski, J., Kosta-Trabka, E., Sotowska, W, Bieron, K., Grodzinska, L., Dembinska-Kiec, A., Pykosz-Mazur, E., Peczak, E. & Gryglewski, RJ. (1985) Double-blind controlled trial of the therapeutic effects of prostacyclin in patients with completed ischaemic stroke. Stroke 16 (5), 810-814.
85. Izumi, Y, Roussel, S., Pinard, E. & Seylaz,J. (1991) Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Afetab. 11, 1025-1030.
86. Jamieson, D.G., Reivich, M., Alves, W., Fazekas, F., Kushner, M., Chawluk, J., Blackman, D., Silver, F. & Alavi, A. (1989) The effect of ganglioside (GM1) treatment in acute ischaemic infarction: a positron emission tomography study. J. Cereb. Blood Flow Metab 9 (Suppl. 1), S602.
87. Jan, M., Buchheit, F. & Tremoulet, M. (1988) Therapeutic trial of intravenous nimodipine in patients with established cerebral vasospasm after rupture of intracranial aneurysms. Xeurosurgery 23, 154-157.
88. Jonsson, G., Gorio, A., Hallman, H. et al. (1984) Effects of GM1 ganglioside on developing and mature serotonin and noradrenalin neurones lesioned by selective neurotoxins. J. Neumsci. Res. 12, 459-475.
89. Karpiak, S.E. & Mahadik, S.P. (1984) Reduction of cerebral oedema with GM1 ganglioside. J. Neurosn. Res. 12, 485-492.
90. Kartin, P., Povse, M. & Skondia, V (1979) Clinical study of piracetam in patients with subacute cerebrovascular accidents. Acta TTierap. 5, 235-243.
91. Kassell, N.F., Haley, E.G., Appersonhausen, C., Stat, M., Alves, W.M., Dorsch, N.W., Fabinyi G., MathesonJ., ReiUy, P., Siu, K., Stokes, B., Stuart, G., Koos, W., Calliauw, L., Selosse, P., Astrup,J., Gjerris, F., Mendelow, A.D., Castel,J.P., Christiaens,J.L., Keravel, Y., Lagarrigue, J., Mourier, K., Phillipon, J. et al. (1996) Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with anaurysmal hemorrhage - a cooperative study in Europe, Australia and New Zealand. J.Xeurosurg. 84(2), 221-228.
92. Kaste, M., Fogelholm, R., Erüä, T., Palomäki, H., Murros, K., Rissanen, A. & Sarna, S. (1994) A randomized, double-blind, placebo-controlled trial of nimodipine in acute ischaemic hemispheric stroke. Slroke25, 1348-1353.
93. Kelly, J.S., Krnjevic, K., Morris, M.E. & Yim, G.K.W. (1969) Anionic permeability of cortical neurones. Exp. Brain Res. 7, 11-31.
94. Kinouchi, H., Mizui, T., Carlson, E., Epstein, GJ. & Chan, P.M. (1991) Focal cerebral ischaemia and the antioxidant system in transgenic mice over-expressing CuZn-superoxide dismutase. J. Cereb. Blood Flow MeTable 21 (Suppl. 2), S423.
95. Kochhar, A., Zivin, J.A., Lyden, P.D. & Mazarella, V (1988) Glutamate antagonist therapy reduces neurologic deficits following complete ischaemia in primates. Arch. Neural. 45, 148-153.
96. Koek, W., Woods, J.H. & \Vmger, G.D. (1988) MK-801, a proposed noncompetitive antagonist of excitatory amino acid transmission produces phencyclidine-like behavioural effect in pigeons, rats and rhesus monkeys. J. Pharmacol. Exp. Ther. 245, 969-974.
97. Krämer, G., Tettenborn, B., Schmutzhard, E., Aichner, F., Schwartz, A., Busse, O., Hornig, C. & Ladurner, G. (1994) Nimodipine in acute ischaemic stroke: Results of the Nimodipine German-Austrian Trial. Cerebrofasc, Dis. 4, 182-188.
98. Lataste, X., Maurer, W., \Vhitehead,J. and the ASCLEPIOS study group (1992) Application \/ of sequential methods to clinical trial in stroke: The Asclepios Study. 2nd World Congress of Stroke, S16.
99. Leach, M J., Swan, J.H., Eisenthal, D., Dopson, M. & Nobbs, M. (1993) BW619C89, a glutamate release inhibitor, protects against focal cerebral ischaemic damage. Stroke 24, 1063-1067.
100. Ledeen, R.\V. (1983) Gangliosides. In Handbook ofjfeumchemistrf, Volume 3 (ed. Lajtha, A.), pp. 41-90. Plenum Press, New York.
101. Lenzi, G.L., Grigoletto, E, Gent, M., Roberts, R.S., Tech, M., Walker, M.D., Easton, J.D., Carolei, A., Dorsey, EC., Rocca, W.A.-, Bruno, R., Patarnello, F., Fieschi, C. & the Early / Stroke Trial Group (1994) Early treatment of stroke with monosialoganglioside GM-1. Efficacy and safety results of the Early Stroke Trial. Stroke 25, 1552-1558.
102. Lesage, A.S., De Loore, K.L., Osikowska-Evers, B., Peelers, L. & LeysenJ.F. (1994) Lubeluzole, a novel neuroprotectant, inhibits the glutamate-activated NOS pathway. Soc. Neurosci. Abstr. 20, 185.
103. Leung, L.W.S. & Desborough, K.A. (1988) APV, an j\-methyl-D-aspartate receptor antagonist, blocks the hippocampal theta rythm in behaving rats. Brain Res. 463, 148-152.
104. Limburg, M. (1996) Very Early Nimodipine Use in Stroke - The first 100 patients - Cooperation between GPs and neurologists. Stroke 27, 172.
105. Limburg, M. & Hijdra, A. (1990) Flunarizine in acute ischaemic stroke: a pilot study. Eut Neural. 30, 121-122.
106. Lubeluzole Study Group, Janssen Research Foundation (1996) Lubeluzole in ischaemic stroke in North America. Stroke 27, 172.
107. Lustig, H., von Brauchitsch, K.L., Chan,J. & Greenberg, D.A. (1992) A novel inhibitor of glutamate Release reduced excitotoxic injury in litro. Neurosci Lett. 143, 229-232.
108. Mabe, H., Nagai, H., Takagi, T., Umemura, S. & Ohno, M. (1986) Effect of nimodipine on cerebral functional and metabolic recovery following ischaernia in the rat brain. Stroke 17, 501-505.
109. Mahoney, FJ. & Barthel, D.W. (1965) Functional evaluation: the Barthel index. Md. St. Afed.J. 14,61.
110. Manev, H., Costa, E., Wroblewski, J.T. & Guidotti, A. (1990) Abusive stimulation of excitatory amino acid receptors: a strategy to limit neurotoxicity. BASEBJ4, 2789-2797.
111. Martin, J. E, Hamdy, N., Nicholl, J., Lewtas, N., Bergvall, U, Owen, P., Syder, D. & Holroyd, M. (1985) Double-blind controlled trial of prostacyclin in cerebral infarction. Stroke 16(3), 386-390.
112. Martinez-Vila, E., Guillen, F., Villanueva, J.A., Matias-Guiu, J., Bigorra, J., Gil, P., Carbonell, A., Martinez-Lage, J.M. (1990) Placebo-controlled trial of nimodipine in the treatment of acute ischaemic cerebral infarction. Stroke 21, 1023-1028.
113. Mathew, N.T., Meyer, J.S., Rivera.VM., Charney, J.Z. & Hartmann, A. (1972) Double-blind evaluation of glycerol therapy in acute cerebral infarction. Lancet 23, 1327-1329.
114. McDonald, J.W., Silverstein, F.S. & Johnston, M.V. (1990) Magnesium reduces N-methyl D aspartate (NMDA)-mediated brain injury in perinatal rats. Neurosci. Lett. 109, 234-238.
115. Meadows, M.E., Fisher, M. & Minematsu, K. (1994) Delayed treatment with a non-competitive NMDA antagonist, CNS 1102, reduces infarct size in rats. Cerebrovasc. Dis. 4, 26-31.
116. Meldrum, B.S., SwanJ.H., Leach, M J., Millan, M.H., Gwinn, R., Kadota, K., Graham, S.H., Chen, J. & Simon, R.P. (1992) Reduction of glutamate release and protection against brain damage by BW1003C87. Brain Res. 593, 1-6.
117. Minematsu, K., Fisher, M., Li, L., David, M.A., Knapp, A.G., Cotter, R.E., McBurney, R.N. & Sotak, C.H. (1993) Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion-weighted MRI. Neurology 43, 397-403.
118. Mohr, J.P., for the American Nimodipine Study Group (1992) Clinical trial of nimodipine in acute ischaemic stroke. Sinke 23, 3-8.
119. Mohr,J.P, Orgogozo,J.M., Harrison, MJ.G., Wahlgren, N.G., Gelmers.J.H., Martinez-Vila, E., Dycka, J. & Tettenborn, D. (1994) Meta-analysis of oral nimodipine trials in acute ischaemic stroke. Cerebrovasc, Dis. 4, 197-203.
120. Monaco, P., Pastore, L., Cottone, S., Conti, A. & Bellinvia, S. (1991) Early treatment of patients with ischaemic stroke: A double-blind study with monosialotetraesosigangiolode (GM1). First International Conference on Stroke, p. 7.
121. Morley, P., Hogan, MJ. & Hakim, A.M. (1994) Calcium-mediated mechanisms of ischaemic injury and protection. Brain Palhol. 4, 34-37
122. Murphy, JJ. & the TRUST study group (1990) Randomised, double-blind, placebo-controlled trial of nimodipine in acute stroke. Lancet 336, 1205-1209.
123. Norris J.W. (1982) Comments on 'Study Design of Stroke Treatments. Stroke 13, 527-528.
124. Morris, J.W., LcBrun, L.H. & Andersen, B.A. for the Canwin study group (1994) Intravenous nimodipine in acute ischaemic stroke. Cmbrorasc. Dis. 4, 194-196.
125. Nowak, L., Bregestovski, P. & Ascher, P. (1984) Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307, 462-465.
126. Oczkowski, WJ., Hachinski, V, BogousslavskyJ., Barnett, H J.M. & Carruthers, S.G. (1989) A double-blind, randomized trial of PY108-068 in acute ischaemic cerebral infarction. Stroke 20, 604-608.
127. Öhman, J. & Heiskanen, O. (1988) Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery. J. Neurosurg. 69, 683-686.
128. Olney, J.W., Labruyere, J. & Price, M.T. (1989) Pathological changes induced in cerebrocortical neurones by phencyclidine and related drugs. Science 244, 1360-1362.
129. Orgogozo, J.M., Capildeo, R., Anagnostou, C.N., Juge, O., Père, J.J., Dartigues, J.F., Steiner, TJ., Yotis, A. & Clifford Rose, F. (1983) Mise au point d'un score neurologique pour l'évaluation clinique des infarctus sylviens. Presse Med 12, 3039-3044.
130. Ozyurt, E., Graham, D.I., Woodruff, G.N. & McCollochJ. (1988) Protective effect of the glutamate antagonists, MK-801, in focal cerebral ischaemia in the cat. J. Cereb. Blood flow MeTable 8, 138-143.
131. Paci, A., Ottaviano, P., Trenta, A., lannone, G., De Santis, L., Lancia, G., Moschini, E., Carosi, M., Amigoni, S. & Caresia, L. (1989) Nimodipine in acute ischaemic stroke: a double-blind controlled study. ActaXeurol. Scand, 80, 282-286.
132. Park, C.K., Nehls, D.G., Graham, D.I., Teasdale, G.M. & McCullochJ. (1988a) Focal cerebral ischaemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischaemia. J. Cereb. Blood Flow MeTable 8, 757-762.
133. Park, O.K., Nehls, D.G., Graham, D.I., Teasdale, G.M. & McCullochJ. (1988b) The glutamate antagonist MK-801 reduces focal ischaemic damage in the rat. Ann, Neural 24, 543-551.
134. Park, C.K., Nehls, D.G., Teasdale, G.M. & McCullochJ. (1989) Effect of the NMDA antagonist MK-801 on the local cerebral blood flow in focal cerebral ischaemia in the rat.J. Cereb. Blood Flow MeTable 9, 617-622.
135. Perraro, F., Tosolino, G., Pertoldi, F., Sbrojavacca, R., Beorchia, A., Del Fabbro, L., Grassi, L., Lestuzzi, A., Mione, V, Moretti, V & Moro, A. (1984) Double-blind placebo-controlled trial of naloxone on motor deficits in acute cerebrovascular disease. Lancet 1,915.
136. Peters, G.R., Hwang, L.-J., Musch, B., Brosse, D.M., OrgogozoJ.M. (1996) Safety and efficacy \/ of 6 mg/kg/day tirilazad mesylate in patients with acute ischémie stroke (TESS study). Stroke 27, 195.
137. Petruk, K.C., West, M., Mohr, G., Weir, B.K., Benoît, E.G., Gentili, F., Disney, L.B., Khan, M.I., Grace, M., Holness, R.O., Karwon, M.S., Ford, R.M., Cameron, G.S., Tucker, W.S., Purves, G.B., MillerJD.R., Hunter, K.M., Richard, M.T., Durity, FA., Chan, R., Clein, L.J., Maroun, F.B. & Godon, A. (1988) Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J. Neurosurg. 68, 505-517.
138. PhilipponJ., Grob, R., Dagreou, F., Guggiari, M., Rivierez, M. & Viars, P. (1986) Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine. Acta Xeurochir. (Wien) 82, 110-114.
139. Pickard, J.D., Murray, G.D., Illingworth, R., Shaw, M.D.M., Teasdale, G.M., Foy, P.M., Humphrey, P.R.D., Lang, D.A., Nelson, R., Richards, P., SinarJ., Bailey, S. & Skene, A. (1989) Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. Br. Med.J. 298, 636-642.
140. Platt, D., HornJ., SummaJ.D., Schmitt-Rüth, R., Reinlein, B., KauntzJ. & Kronen, E. (1992) Zur Wirksamheit von Piracetam bei geriatrischen Patienten mit akuter zerebraler Ischaemie - eine klinisch kontrollierte Doppelblindstudie. Aled. MM 43, 181-190.
141. Poignet, H., NowickyJ.P. & Scatton, B. (1992) Lack of neuroprotcctive effect of some sigma ligands in a model of focal cerebral ischaemia in the mouse. Brain Res. 596, 320-324.
142. Prange, H., Härtung, J., Hertel, G., Herrlinger, D., Hülser, G., Kornhuber, H.H., Peters, T. & Seiler, K.U. for the German Flunarizine Group (1991) Treatment of acute stroke with flunarizine i.v. Int Confon Stroke, Geneva, Switzerland, p. 39.
143. Price, T.H., Beatty, P.G. & Corpuz, S.R. (1987) In mo inhibition of neutrophil function in the rabbit using monoclonal antibody to CD IS.J.Immunol. 139,4174-4177.
144. Rankin,J. (1957) Cerebrovascular accidents in patients over the age of 60: II. Prognosis. Scot. Med. J. 2, 200-215.
145. RANTTAS investigators (1996) Randomized trial of tirilazad in acute stroke (RANTTAS) Stroke 27, 195.
146. Reddy, N.L., Hu, L.Y., Cotter, R.E., Fischer, J.B., Wong, WJ., McBurney, R.N., Weber, E., Holmes, D.L., Wong, S.T., Prasad, R. et al. (1994) Synthesis and structure-activity studies of .A'j./V'-diarylguanidine derivatives. .Ac(l-naphtyl)-./V'-(3-ethylphenyl)-7Vr'-methyIguanidine: a new, selective noncompetitive NMDA receptor antagonist, j. Med. Chem. 37, 260-267.
147. Sauter, A., Wiederhold, K.H. & Rudin, M. (1990) Isradipine improves short- and long-term outcome of ischaemic stroke in rat middle cerebral artery occlusion model: Mechanisms of action. Stroke 21 (Suppl. 1), 1-158.
148. Serieller, D., Kolb,J., Szathmary, S., Zacharias, E., De Ryck, M., Van ReemptsJ., Clincke, B. & Tegtmeier, F. (1995) Extracellular changes of glutamate in the peri-infarct zone: effect of lubeluzole. J. Cereb. Blood Flow MeTable 15 (Suppl. 1), S379.
149. Seifert, W. (1981) Gangliosides in nerve cell cultures. In Gangliosides in Neurological and Nsuromuscular Function, Development and Repair (eds Rapport, M.M. & Gorio, A.), pp. 99-117. Raven Press, New York.
150. Sen S. & PhyllisJ.W. (1993) alpha-Phenyl-tert-butyl-nitrone (PBN) attenuates hydroxyl radical production during ischaemia-reperfusion injury of rat brain: an EPR study. Free Radie. Res. Commun. 19, 255-265.
151. Sherman, D.G., Easton,J.D., Hart, R.G.,-Sherman, C.P. & Battye, R. (1986) Nimodipine in acute cerebral infarction. A double-blind.study of safety and efficacy. In Acute Brain Ischaemia: Medical and Surgical Therapy (eds Battistini, N., Fiorani, P., Courier, E, Plum, F. & Fieschi, C.), pp. 257-262. Raven Press, New York.
152. Shuaib, A., Hasan, S. & Kalra,J. (1992) Gamma-vinyl GABA prevents hippocampal and substantia nigra reticulata damage in repetitive transient forebrain ischaemia. Brain Res. 590, 13-17.
153. Shuaib, A., Mazagri, R. & Liaz, S. ( 1993) GABA agonist 'Muscimol' is neuroprotective in repetitive transient forebrain ischaemia in gerbils. Exp. Neurol. 123, 284-288.
154. Siesjö, B.K., Agardh, C.D. & Bengtsson, F. (1989) Free radicals and brain damage. Cerebrovasc. Brain Metab Rev. 1, 165-211.
155. Sills, M.A. & Loo, P.S. (1989) Tricyclic antidepressants & dextromethorphan bind with higher affinity to the phencycline receptor in the absence of magnesium & L-glutamate. Mol. Pharmacol. 36, 160-165.
156. Smith, C.W., Rothlein, R., Highes, B J., Mariscalco, M.M., Schmalstieg, EC. & Person, D.C. (1988) Recognition of an endothelial determinant for CD 18 dependent human neurophil adherence & transendothelial migration. J. Clin. Invest. 82, 1746-1756.
157. Smith, S.E., Lekieffre, D., Sowinski, P. & Meldrum, B.S. (1993) Cerebroprotective effect of BW619C89 after focal or global cerebral ischaemia in the rat. Neuroreport 4, 1339-1342.
158. Snape, M.F., Baldwin, H.A., Cross, AJ. & Green, A.R. (1993) The effects of clormethiazole & nimodipine on cortical infarct area after focal cerebral ischaemia in the rat. Jteuroscience 53, 837-844.
159. Staunton, D.E., Merluzzi, VJ., Rothlein, R., Barton, R., Mariin, S.D. & Springer, TA. (1989) A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 56, 849-853.
160. Steinberg, G.K., George, C.P., DeLaPaz, R., Shibata, O.K. & Gross, T. (1988a) Dextromethorphan protects against cerebral injury following transient focal ischaemia in rabbits. Stroke 19, 1112-1118.
161. Steinberg, G.K., Saleh, J. & Kunis, D. (1988b) Delayed treatment with dextromethorphan and dextrorphan reduces cerebral damage after transient focal ischaemia. Neurosci. Lett. 89, 193-197.
162. Steinberg, G.K., Saleh, J., Kunis, D., De La Paz, R. & Zarnegar, S.R. (1989) Protective effect of .A-methyl-D-aspartate antagonist after focal ischaemia in rabbits. Stroke 20, 1247-1252.
163. STIPAS investigators (1994) Safety study of Tirilazad mesylate in patients with acute ischaemic stroke (STIPAS). Stroke 25, 418-423.
164. Strand, T., Wester, P.O. et al. (1993) A double blind randomized pilot trial of magnesium therapy in acute cerebral infarction. 7th Nordic Meeting on Cmbrorascular Diseases, p. 37.
165. Svennerholm, L. (1984) Biological significance ofgangliosides. In Cellular and Pathological Aspects of Gljcoconjugate Metabolism (eds Dreyfus, H. et al.),pp. 21-44. INSERAI, Paris.
166. Swan, J.H. & Meldrum, B.S. ( 1989) Early, not late, administration of NMDA receptor antagonists protects against selective ischaemic cell loss. J. Cereb. Blood Flow MeTable 9 (Suppl. 1), S558.
167. Synthélabo Recherche (1996) Press Release, Paris, February 6.
168. Tazaki, Y, Sakai, F. & Otomo, E. (1988) Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study. Stroke 19, 211-216.
169. Tettamanti, G., Sonnino, S., Ghidoni, R., Masserini, M. & Venero, B. (1985) Chemical and functional properties ofgangliosides. Their possible implication in the membrane-mediated transfer of information. In Physics ofAmphiphiles: micelles, vesicles and microemulsions (eds de Giorgio, V & Corti, M.), pp. 607-636. XC Corso Società Italiana di Fisica, Bologna.
170. Toffano, M., Savoini, G.E., Moroni, F., Lombard!, G., Calza, L. & Agnati, L. (1983) GM1 gangliosides stimulates the regeneration of dopaminergic neurones in the central nervous system. Brain Res 261, 163-166.
171. Tsuda, T., Kogure, K., Nishioka, K. & Watanabe, T. (1991) Mg2+ administered up to twenty-four hours following reperfusion prevents ischaemic damage of the CA1 neurones in the rat hippocampus. Neuroscience 44, 335-341.
172. Turrini, R. (1996) A pivotal safety and efficacy of Cerestat (Aptiganel HCL/CNS 1102) in acute ischaemic stroke patients. Stroke 27, 173.
173. Uematsu, D., GreenbergJ.H., Hickey, W.F., & Reivieh, M. (1989) Nimodipine attenuates both increase in cytosolic free calcium & histologie damage following focal cerebral ischaemia and reperfusion in cats. Stroke 20, 1531-1537.
174. Van Nuetan, J.M. & Vanhoutte, P.M. (1984) Flunarizine. In New Drugs Annual, Volume 2, Cardiovascular Drugs (ed. Scriabine, A.), pp. 245-266. Raven Press, New York.
175. Vorstrup, S., & Persen, A., Blegvad, N. & Paulson, O.B. (1986) Calcium antagonist (PY 108-068) treatment may further decrease flow in ischaemic areas in acute stroke. J. Cereb. Blood Flow MeTable 6, 222-229.
176. Wahlgren, N.G. (1995) Cytoprotective therapy for acute ischaemic stroke. In Stroke Therapy (ed. Fisher, M.), pp. 315-350. Butterworth & Heinemann, Boston.
177. Wahlgren, N.G., MacMahon, D., De Keyser, J., Indredavik, B. & Ryman, T. for the INWEST study group (1994) Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke. Cerebroi'osc. Dis. 4, 204-210.
178. Warkins.J.C. & Olverman, H J. (1987) Agonists & antagonists for excitatory amino acid recep-tors. Trends Neurosci. 10, 265-272.
179. Wender, M., Mularek, J., Godlewski, A., Losy, J., Michalowska Wender, G., Sniatala Kamasa, M. & Wojcicka, M. (1993) Trials of monosialoganglioside (Sygen) treatment in ischaemic stroke. Neural. Neurochir. Pol. 27, 31-38.
180. Wiernspcrger, N., Gygax, P. & Hofmann, A. (1984) Calcium antagonist PY 108-068.
181. Demonstration of its efficacy in various types of experimental brain ischaemia. Stroke 15, 679-685.
182. Williams, K., Romano, G., Dichter, M.A. & MolinofT, P.B. (1991) Modulation of the NMDA receptor by polyamines. Life Sei. 48, 469-498.
183. Wimalaratna, H.S.K. & Capildeo, R. (1994) Nimodipine in acute ischaemic cerebral hemisphere infarction. Cerebrorasc. Dis. 4, 179-181.
184. Wojcik, M., UlasJ. & Oderfield-Nowak, B. (1982) The stimulating effect of ganglioside injections on the recovery of choline acetyltransferase and acetylcholinesterase activities in the rat after septal lésions. Neuroscience 7, 495-499.
185. Wong, E.H., Kemp,J.A., Priestley, T., Knight, A.R., Woodruff, G.N. & Iversen, L.L. (1986) The anticonvulsant MK-801 is a potent .A-methyl-D-aspartate antagonist. Proc.NatlAcad. Sei. USA 83,7104-7108.
186. Woollard, M.L., Pearson, R.M., Griffith, D. &James, I.M. (1978) Controlled trial of ornithine alpha ketoglutarate (OAKG) in patients with stroke. Stroke 9, 218-222.
187. Xue, D., Slivka, A. & Buchan, A.M. (1992) Tirilazad reduces cortical infarction after temporary but not permanent focal cerebral ischaemia in rats. Stroke 23, 894-899.
188. Youker, K., Smith, C.W. & Person, D.C., Miller, D., Michael, L.H., Rossen, R.D. & Entman, M.L. (1992) Neutrophil adherence to isolated adult cardiac myocytes: induction by cardical lymph collected during ischaemia & infarction. J. Clin. Imest. 89, 602-609.
189. Yue, T.L., Gu, J.L., Lysko, P.G., Cheng, H.Y., Barone, EC. & Feuerstein, G. (1992) Neuroprotective effects of phenyl-t-butyl-nitrone in gerbil global brain ischaemia and in cultured rat cerebellar neurones. Brain Res. 574, 193-197.
190. Zhang, R.L., Chopp, M., Zaloga, C., Jiang, M., Jones, M., Miyasaka, M. & Ward, P. (1994) Anti-ICAM-antibody reduces ischaemic cell damage after transient middle cerebral artery occlusion in the rat. Neurology 44, 1747-1751.
191. Zhang, R.L., Chopp, M., Jiang, N., Tang, W.X., Prostak,J., Manning, A.M. & Anderson, D.C. (1995) Anti-intercellular adhesion molecule-1 antibody reduces ischaemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke 26, 1438-1443.
192. Zimmerman, G.A. & Mclntyre, T.M. (1988) Neutrophil adherence to human endothelium in vitro occurs by Cdw 18 (Mol. MAC-1/LFA-1/GP150,95) glycogen-dependent and -independent mechanisms. J. Clin. Invest. 81, 531-537.